Rigel Pharmaceuticals Inc
NASDAQ:RIGL
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Rigel Pharmaceuticals Inc
NASDAQ:RIGL
|
US |
|
Bruker Corp
NASDAQ:BRKR
|
US |
|
Sika AG
F:SIKA
|
CH |
|
NVE Corp
NASDAQ:NVEC
|
US |
|
Mesoblast Ltd
ASX:MSB
|
AU |
|
BlackBerry Ltd
TSX:BB
|
CA |
|
TomTom NV
F:OEMB
|
NL |
|
C
|
Cincinnati Financial Corp
F:CCJ
|
US |
|
Koninklijke BAM Groep NV
AEX:BAMNB
|
NL |
Intrinsic Value
The intrinsic value for
Rigel Pharmaceuticals Inc (RIGL) under the Base Case is hidden
USD.
Compared with the current market price of 28.3 USD, the stock appears hidden
.
RIGL looks undervalued. But is it really? Some stocks live permanently below intrinsic value; one glance at Historical Valuation reveals if RIGL is one of them.
Learn how current stock valuations stack up against historical averages to gauge true investment potential.
Let our AI compare Alpha Spread’s intrinsic value with external valuations from Simply Wall St, GuruFocus, ValueInvesting.io, Seeking Alpha, and others.
Let our AI break down the key assumptions behind the intrinsic value calculation for Rigel Pharmaceuticals Inc.
Fundamental Analysis
Revenue & Expenses Breakdown
Rigel Pharmaceuticals Inc
Earnings Waterfall
Rigel Pharmaceuticals Inc
The intrinsic value for
Rigel Pharmaceuticals Inc (RIGL) under the Base Case is hidden USD.
Compared with the current market price of 28.3 USD, the stock appears hidden.